Healthcare professionals

  • Email
  • Help

The European Medicines Agency (EMA) has been interacting with European healthcare professionals in various areas of its work since it was founded in 1995. As prescribers and handlers of the medicines that the Agency evaluates, healthcare professionals are key stakeholders in the Agency's work and have specific knowledge and expertise to offer. The Agency is committed to maintaining a strong working relationship with this group.

Key milestones of EMA interaction with healthcare professionals

Download image in PDF format

Framework for interaction

In December 2016, the EMA Management Board endorsed the revised framework for interaction between EMA and healthcare professionals and their organisations:

The framework describes the objectives and the terms of reference for this interaction and aims to:

  • support the Agency in accessing the best independent expertise in any matter related to medicines;
  • contribute to more efficient and targeted communication to healthcare professionals;
  • enhance understanding of the role of the EU medicines regulatory network.

This framework is in line with EMA's overarching framework for stakeholder relations management, which the EMA Management Board adopted in June 2016:

Activities of healthcare professionals

Healthcare professionals are involved in a wide range of activities at the Agency, including:

  • as members of the Management Board;
  • as members of its scientific committees;
  • responding to specific requests from the Agency’s scientific committees and working parties;
  • taking part in discussions on the development and authorisation of medicines;
  • reviewing written information on medicines prepared by the Agency;
  • being involved in the preparation of guidelines;
  • taking part in Agency conferences and workshops.

Stakeholder engagement report 2017

EMA publishes an annual report on its interactions with patients, consumers, healthcare professionals, academics and their organisations, incorporating both quantitative and qualitative data.

For previous reports, see Key documents.

More information

How helpful is this page?

Average rating:

 Based on 43 ratings

Add your rating:

See all ratings
10 ratings
7 ratings
7 ratings
9 ratings
10 ratings

Tell us more

Working with healthcare professionals - leaflet

Biosimilars in the EU - information guide

Leaflet biosimilars

Factsheet: Patients, consumers, healthcare professionals key figures

Infosheet- Patients consumers and healthcare professionals